In a shocking twist for the genetic testing company 23andMe, all seven members of its board resigned at once, putting founder Anne Wojcicki’s leadership under intense scrutiny. While Wojcicki believes her startup can still be saved, the challenges ahead are significant.
A Rocky Road to Success
Founded in 2006, 23andMe initially thrived on the novelty of personal genetic testing. The company…
